Addex Therapeutics (ADXN) Long-Term Investments (2018 - 2026)

Addex Therapeutics has reported Long-Term Investments for 9 years, with the latest figure at $69651.7 in Q1 2026.

• Quarterly Long-Term Investments fell 99.0% year-over-year to $69651.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69651.7 (down 99.0% YoY) and the FY2025 annual result came in at $8546.6, down 99.89% from the prior year.
• Long-Term Investments climbed to $69651.7 in Q1 2026 per ADXN's latest filing, from $8865.8 in the prior quarter.
• Over five years, Long-Term Investments peaked at $9.8 million in Q2 2024 and troughed at $8100.0 in Q1 2024.
• A 5-year average of $1.5 million and a median of $60446.7 in 2023 frame the typical range for Long-Term Investments.
• The widest YoY moves for Long-Term Investments: up 85580.52% in 2025, down 99.89% in 2025.
• Over 5 years, Long-Term Investments stood at $56421.7 in 2022, then advanced by 8.58% to $61265.0 in 2023, then soared by 13105.15% to $8.1 million in 2024, then sank by 99.89% to $8865.8 in 2025, then surged by 685.62% to $69651.7 in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $69651.7, $8865.8, and $8859.5 for Q1 2026, Q4 2025, and Q3 2025 respectively.